# Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Study · id `cardio:ct-nct06310031` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06310031](<https://clinicaltrials.gov/study/NCT06310031>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06310031

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 780 participants.

## Technical summary

Registry record NCT06310031. Randomized; no masking; primary purpose treatment. Start 2024-10-28 (actual); primary completion 2028-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 780 participants (planned count; ClinicalTrials.gov record NCT06310031, source copy `cardio:ctgov-nct06310031-2026-11-05`, retrieved 2026-11-18)
- Started: 2024-10-28 (actual) (ClinicalTrials.gov record NCT06310031, source copy `cardio:ctgov-nct06310031-2026-11-05`, retrieved 2026-11-18)
- Primary completion: 2028-02 (anticipated) (ClinicalTrials.gov record NCT06310031, source copy `cardio:ctgov-nct06310031-2026-11-05`, retrieved 2026-11-18)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT06310031, source copy `cardio:ctgov-nct06310031-2026-11-05`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT06310031, source copy `cardio:ctgov-nct06310031-2026-11-05`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06310031-2026-11-05`, retrieved 2026-11-18)

## The registry's words

- Brief title: Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Acronym: INNOVATE
- Condition: Cardiovascular Diseases
- Condition: Heart Diseases
- Condition: Heart Failure
- Intervention (Device): BrioVAD System
- Intervention (Device): HeartMate 3
- Lead sponsor: BrioHealth Solutions, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 86ef0b37cbf85d2a9b93e35e54cf11b1953ca0753a53f097f599f6be054eb997
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
